Welcome to our dedicated page for ALLURION TECHNOLOGIES SEC filings (Ticker: ALUR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SEC filings for a medical-device pioneer can read like an FDA submission. With clinical-trial endpoints, digital-health KPIs, and reimbursement footnotes, finding what matters in Allurion Technologies’ disclosures is tough. Allurion Technologies SEC filings explained simply is exactly what investors search for, and it’s what Stock Titan delivers.
Open any document in our dashboard and you’ll see AI-powered highlights that answer questions such as “What did R&D look like in the latest Allurion Technologies quarterly earnings report 10-Q filing?” or “Are there new risk factors tied to balloon recalls?” Real-time crawlers flag Allurion Technologies Form 4 insider transactions real-time, letting you review Allurion Technologies insider trading Form 4 transactions minutes after they hit EDGAR. Interactive charts pair with Allurion Technologies earnings report filing analysis so you can track margins, device placement volumes, and subscription revenue without wading through hundreds of pages. It’s all part of understanding Allurion Technologies SEC documents with AI.
In one visit you can scan an Allurion Technologies annual report 10-K simplified, drill into Allurion Technologies executive stock transactions Form 4, or preview an upcoming Allurion Technologies proxy statement executive compensation discussion. Sudden developments—clinical study results, CE-mark milestones, or financing updates—arrive as Allurion Technologies 8-K material events explained in plain English. Whether you monitor insider buying ahead of pivotal trials or compare quarter-over-quarter unit growth, Stock Titan’s AI ensures you never miss a disclosure that could move the market.
Morgan Stanley Finance LLC, guaranteed by Morgan Stanley, is offering Worst-of Energy Select Sector SPDR Fund (XLE) and SPDR S&P Oil & Gas Exploration & Production ETF (XOP) Contingent Income Auto-Callable Securities maturing on January 14 2027.
- Contingent coupon: 9.60% p.a., paid monthly only if the closing level of each underlier on the relevant observation date is ≥ 70% of its initial level.
- Auto-call feature: Beginning six months after pricing, the notes are automatically redeemed at par on any monthly determination date when each underlier closes ≥ 100% of its initial level; no further coupons accrue thereafter.
- Downside exposure: At maturity, if not previously called and the worst-performing underlier is ≥ 70% of its initial level, investors receive par. Otherwise, repayment is reduced 1-for-1 with the worst underlier’s decline, exposing investors to up to 100% loss of principal.
- Key dates: Pricing – July 11 2025; Final observation – January 11 2027; Maturity – January 14 2027.
- Estimated value: $960.20 per $1,000 note (within ±$35), reflecting structuring and hedging costs.
- Notes are senior, unsecured obligations of MSFL, unlisted, and subject to Morgan Stanley credit risk.
The product suits investors seeking high contingent income tied to energy sector ETFs, willing to bear equity, concentration, liquidity and issuer credit risks, and accepting potential loss of principal below the 70% threshold.
FAQ
What is the current stock price of ALLURION TECHNOLOGIES (ALUR)?
What is the market cap of ALLURION TECHNOLOGIES (ALUR)?
What is the core focus of Allurion Technologies Inc?
How does the Allurion Program work?
What distinguishes Allurion's weight loss solution from traditional methods?
Who can benefit from Allurion's weight loss platform?
How is advanced technology integrated into Allurion's services?
How does Allurion maintain trust and safety in its offerings?
